Protective efficacy of two novel DNA vaccines expressing Toxoplasma gondii rhomboid 4 and rhomboid 5 proteins against acute and chronic toxoplasmosis in mice

References

• Dubey JP. Toxoplasmosis of animals and humans. CRC Press, Inc; Boca Raton, New York: 2010, p. 1-313
   Google Scholar
• Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965-76
   PubMed Web of Science ®Google Scholar
• Weiss LM, Dubey JP. Toxoplasmosis: a history of clinical observations. Int J Parasitol 2009;39:895-901
   PubMed Web of Science ®Google Scholar
• Fayer R, Dubey JP, Lindsay DS. Zoonotic protozoa: from land to sea. Trends Parasitol 2004;20:531-6
   PubMed Web of Science ®Google Scholar
• Dubey JP, Hill DE, Jones JL, et al. Prevalence of viable Toxoplasma gondii in beef, chicken, and pork from retail meat stores in the United States: risk assessment to consumers. J Parasitol 2005;91:1082-93
   PubMed Web of Science ®Google Scholar
• Zhang NZ, Chen J, Wang M, et al. Vaccines against Toxoplasma gondii: new developments and perspectives. Expert Rev Vaccines 2013;12:1287-99
   PubMed Web of Science ®Google Scholar
• Buxton D, Thomson K, Maley S, et al. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet Rec 1991;129:89-93
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 2000;18:927-74
   PubMed Web of Science ®Google Scholar
• Hoft DF, Eickhoff CS, Giddings OK, et al. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic Trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J Immunol 2007;179:6889-900
   PubMed Web of Science ®Google Scholar
• Xenopoulos A, Pattnaik P. Production and purification of plasmid DNA vaccines: is there scope for further innovation? Expert Rev Vaccines 2014;13:1537-51
   PubMed Web of Science ®Google Scholar
• Hoffman SL, Doolan DL, Sedegah M, et al. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use. Vaccine 1997;15:842-5
   PubMed Web of Science ®Google Scholar
• Chen J, Huang SY, Zhou DH, et al. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Vaccine 2013;31:6225-31
   PubMed Web of Science ®Google Scholar
• Zhang NZ, Huang SY, Zhou DH, et al. Protective immunity against Toxoplasma gondii induced by DNA immunization with the gene encoding a novel vaccine candidate: calcium-dependent protein kinase 3. BMC Infect Dis 2013;13:512
   PubMed Web of Science ®Google Scholar
• Chen J, Li ZY, Petersen E, et al. DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice. Expert Rev Vaccines 2015;14:489-92
   PubMed Web of Science ®Google Scholar
• Dowse TJ, Soldati D. Rhomboid-like proteins in Apicomplexa: phylogeny and nomenclature. Trends Parasitol 2005;21:254-8
   PubMed Web of Science ®Google Scholar
• Dowse TJ, Soldati D. Host cell invasion by the apicomplexans: the significance of microneme protein proteolysis. Curr Opin Microbiol 2004;7:388-96
   PubMed Web of Science ®Google Scholar
• Brossier F, Jewett TJ, Sibley LD, Urban S. A spatially localized rhomboid protease cleaves cell surface adhesins essential for invasion by Toxoplasma. Proc Natl Acad Sci USA 2005;102:4146-51
   PubMed Web of Science ®Google Scholar
• Buguliskis JS, Brossier F, Shuman J, Sibley LD. Rhomboid 4 (ROM4) affects the processing of surface adhesins and facilitates host cell invasion by Toxoplasma gondii. PLoS Pathog 2010;6:e1000858
   PubMed Web of Science ®Google Scholar
• Chen J, Huang SY, Li ZY, et al. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine 2013;25:1734-9
   Google Scholar
• Zhang NZ, Huang SY, Xu Y, et al. Evaluation of immune responses in mice after DNA immunization with putative Toxopalsma gondii calcium-dependent protein kinase 5. Clin Vaccine Immunol 2014;21:924-9
   PubMed Web of Science ®Google Scholar
• Dowse TJ, Pascall JC, Brown KD, Soldati D. Apicomplexan rhomboids have a potential role in microneme protein cleavage during host cell invasion. Intl J Parasitol 2005;35:747-56
   PubMed Web of Science ®Google Scholar
• Kim K. Role of proteases in host cell invasion by Toxoplasma gondii and other Apicomplexa. Acta Trop 2004;91:69-81
   PubMed Web of Science ®Google Scholar
• Dowse TJ, Koussis K, Blackman MJ, Soldati-Favre D. Roles of proteases during invasion and egress by Plasmodium and Toxoplasma. Subcell Biochem 2008;47:121-39
   PubMedGoogle Scholar
• Li J, Han Q, Gong P, et al. Toxoplasma gondii rhomboid protein 1 (TgROM1) is a potential vaccine candidate against toxoplasmosis. Vet Parasit 2012;184:154-60
   PubMed Web of Science ®Google Scholar
• Bessieres MH, Swierczynski B, Cassaing S, et al. Role of IFN-gamma, TNF-alpha, IL-4 and IL-10 in the regulation of experimental Toxoplasma gondii infection. J Eukaryot Microbiol 1997;44:87S
   PubMed Web of Science ®Google Scholar
• Sturge CR, Benson A, Raetz M, et al. TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens. Proc Natl Acad Sci USA 2013;110:10711-16
   PubMed Web of Science ®Google Scholar
• Sánchez-Valdéz FJ, Pérez Brandán C, Ferreira A, Basombrío MA. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease. Expert Rev Vaccines 2014;11:1-17
   Google Scholar
• Scott P & Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr Opin Immunol 1995;14:466-70
   Google Scholar
• Denkers EY, Gazzinelli RT. Regulation and function of T-Cell-Mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998;11:569-88
   PubMed Web of Science ®Google Scholar
• Sibley LD. Invasion and intracellular survival by protozoan parasites. Immunol Rev 2011;240:72-91
   PubMed Web of Science ®Google Scholar
• Gazzinelli R, Xu Y, Hieny S, et al. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol 1992;149:175-80
   PubMed Web of Science ®Google Scholar
• Sayles PC, Gibson GW, Johnson LL. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun 2000;68:1026-33
   PubMed Web of Science ®Google Scholar